Flash Radiotherapy & Particle Therapy - FRPT Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Flash Radiotherapy & Particle Therapy - FRPT Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Flash Radiotherapy & Particle Therapy (FRPT & SFRT) Conference
The FRPT & SFRT 2026 Conference brings together an international community focused on two closely related advances in radiation oncology: Flash Radiotherapy and Spatially Fractionated Radiotherapy (SFRT). Held as a dedicated forum for researchers, clinicians, and technical experts, the event is designed to connect pioneering science with real-world clinical translation—exploring the latest research directions, clinical trial insights, and practical implementation challenges shaping the future of oncology treatment.
This conference is positioned as a meeting place where physics meets cure, continuing the tradition established since 2021. In 2026, the conference expands its scope by welcoming innovators working specifically on Spatially Fractionated Radiation Therapy (SFRT), alongside the established Flash radiotherapy community.
Dates & Format
2–5 December 2026
Lisbon & Online
Venue & Location
The event is hosted in Lisbon (with an additional online component). The official website text confirms the city and the dual delivery format, while specific venue details are not provided in the supplied content.
Who Should Attend
The FRPT & SFRT Conference is well suited for stakeholders who want to engage deeply with the cutting edge of radiotherapy innovation, including those driving research, evaluating clinical evidence, and planning future studies and deployments. Attendees can expect a mix of expert-led plenaries and in-depth discussions, bringing together perspectives across oncology treatment development.
What the Program Emphasizes
Over four dynamic days, the conference explores the most recent developments in radiation therapy by featuring:
- Latest RT advancements and ongoing work relevant to Flash radiotherapy and SFRT
- Immersive learning sessions designed to support both scientific understanding and clinical application thinking
- Clinical trial insights that highlight the evolving evidence base and research momentum
- Plenaries and discussions led by experts in the field
- Opportunities to join the community through networking and conference engagement
Why It Matters
Radiotherapy innovation depends on collaboration across disciplines—particularly between physics, clinical oncology, translational research, and technology development. The FRPT & SFRT Conference is built to accelerate that collaboration by concentrating on advanced radiotherapy methods that are redefining how oncology treatment may evolve.
Registration Updates
Early Registration Savings are available until 9 September, with an invitation to register early and save. The conference also includes pathways for attendees to view the programme and register for participation.
Data sheet
Flash Radiotherapy & Particle Therapy - FRPT Conference – Event Attendee & Buyer Profile Analysis
Event Date: 2–5 December 2026
Location: Lisbon, Portugal
Event Status: Upcoming
Research Date: 1 July 2026
Event Overview
| Event Name | Flash Radiotherapy & Particle Therapy - FRPT Conference |
| Event Date | 2–5 December 2026 |
| Event Status | Upcoming |
| Venue | Lisbon & Online; specific physical venue not publicly confirmed in the provided official text |
| City | Lisbon |
| State / Region | Lisbon Region |
| Country | Portugal |
| Organizer | Not publicly confirmed in the provided official text |
| Official Event Website | frpt-conference.org |
| Event Type | International scientific conference / hybrid event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Global, with strong European oncology and radiotherapy participation potential |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium for event format and positioning; low for headcount because no official attendance figure was provided in the available source text |
| Main Purpose of Event | To convene radiotherapy, particle therapy, FLASH radiotherapy, and SFRT specialists for research exchange, clinical trial insights, education, and industry networking |
About the Event
FRPT & SFRT 2026 is a specialized international conference focused on FLASH radiotherapy, particle therapy, and spatially fractionated radiation therapy. The event positions itself as a high-level scientific and clinical forum where innovators, researchers, clinicians, and technology stakeholders can exchange evidence, review trial progress, and discuss the next generation of oncology treatment approaches.
The conference matters because it sits at the intersection of oncology care, advanced radiation technology, clinical translation, and research commercialization. Its attendee base is likely to include hospital and cancer-center decision makers, radiation oncologists, medical physicists, researchers, treatment-planning specialists, and industry partners involved in devices, software, dosimetry, imaging, and therapy delivery systems. This makes the event highly relevant for B2B lead generation in medical technology, research services, and clinical infrastructure markets.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hospital and cancer center procurement teams | Academic medical centers, oncology hospitals, cancer institutes | Purchase and vendor evaluation for treatment systems, software, and services | High-value target for therapy equipment, planning software, QA, and service contracts |
| Radiation oncology department leaders | Hospitals, cancer centers, private radiotherapy clinics | Clinical decision-maker for therapy adoption and workflow upgrades | Influence purchasing of radiotherapy platforms, accessories, and clinical tools |
| Medical physicists and dosimetry teams | Cancer centers, university hospitals, research hospitals | Technical evaluators for planning, QA, measurement, and safety systems | Strong audience for dosimetry, QA, detectors, imaging, and planning solutions |
| Radiation therapy researchers | Universities, research institutes, translational oncology programs | Research collaboration, trial design, and technology validation influence | Relevant for research tools, preclinical systems, imaging, and analytics providers |
| Particle therapy center operators | Proton therapy centers, ion therapy centers, specialty oncology facilities | Operational and investment decision-making around high-capex treatment systems | Very relevant for accelerators, beam delivery, controls, service, and facility planning |
| Clinical trial teams | Hospitals, CROs, academic consortia, investigator networks | Evaluate trial technologies, data systems, and research partnerships | Relevant for clinical research services, data capture, imaging, and trial software |
| Biomedical engineering and equipment teams | Hospitals, healthcare systems, equipment service providers | Technical review, equipment lifecycle management, vendor coordination | Good fit for maintenance, calibration, integration, and service suppliers |
| Vendor and industry partners | Medical device firms, software vendors, service providers, labs | Solution selling, sponsorship, partnerships, and demonstration | Important for exhibitor ROI and commercial conversations |
| Association leaders and scientific organizers | Radiotherapy societies, oncology associations, research networks | Influence education, standards, and partnership opportunities | Useful for sponsorship, education, and thought-leadership outreach |
| Public-sector health decision makers | National health systems, ministries, public oncology programs | Funding, acquisition, and treatment-access planning | Relevant for infrastructure, imaging, and clinical modernization suppliers |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Lisbon | Local hospitals, universities, oncology centers, and biotech stakeholders | Medium | Local attendance is likely due to onsite format in Lisbon |
| Host region: Portugal | National oncology, public health, and academic institutions | Medium | Portugal has a concentrated health research and hospital network that can support attendance |
| Nearby European hubs | Spain, France, Germany, Italy, UK, Benelux, Nordics | High | European radiotherapy and oncology networks are likely to be well represented |
| International research community | Global academic centers, translational research groups, industry specialists | High | The subject matter is niche but globally relevant, supporting cross-border participation |
| Transatlantic / global specialist attendees | US, Canada, Asia-Pacific, Middle East specialists | Medium | Likely among investigators, product leaders, and advanced therapy vendors |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The subject matter is specialized and internationally relevant, with a hybrid format that supports participation beyond Portugal and Europe |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| The Christie NHS Foundation Trust | Hospital / cancer center | Major oncology institution with likely interest in advanced radiotherapy innovation | christie.nhs.uk | Head of Radiotherapy, Clinical Director, Medical Physics Lead | Strong Market Fit, Attendance Not Confirmed |
| MD Anderson Cancer Center | Cancer center | Global oncology leader likely to track FLASH and particle therapy developments | mdanderson.org | Chair, Radiation Oncology, Research Director, Physicist Lead | Strong Market Fit, Attendance Not Confirmed |
| Mass General Brigham | Health system | Large academic system with radiology, oncology, and research purchasing influence | massgeneralbrigham.org | Director of Oncology, Procurement Manager, Medical Physics Director | Strong Market Fit, Attendance Not Confirmed |
| Charité – Universitätsmedizin Berlin | University hospital | European academic medicine and research buyer for advanced oncology technology | charite.de | Head of Radiation Oncology, Research Coordinator, Biomedical Engineering Lead | Strong Market Fit, Attendance Not Confirmed |
| Gustave Roussy | Cancer institute | High-profile oncology center likely to evaluate cutting-edge radiotherapy approaches | gustaveroussy.fr | Oncology Director, Physicist, Clinical Trials Manager | Strong Market Fit, Attendance Not Confirmed |
| UK National Health Service trusts | Public healthcare buyers | Procurement for radiotherapy equipment, services, and clinical workflow tools | nhs.uk | Procurement Lead, Radiotherapy Service Manager, Clinical Engineering Manager | Strong Market Fit, Attendance Not Confirmed |
| Royal Marsden NHS Foundation Trust | Cancer hospital | Specialist cancer center with strong innovation and trial orientation | royalmarsden.nhs.uk | Head of Radiotherapy, Research Nurse Lead, Physics Manager | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Hospital system | Advanced care delivery and research institution with significant clinical technology needs | mayoclinic.org | Radiation Oncology Chair, Director of Research, Procurement Director | Strong Market Fit, Attendance Not Confirmed |
| Paul Scherrer Institute | Research institute | Particle therapy and radiobiology research relevance | psi.ch | Research Lead, Accelerator Physicist, Lab Director | Strong Market Fit, Attendance Not Confirmed |
| Varian, a Siemens Healthineers company | Medical technology vendor | Treatment planning and radiotherapy ecosystem participant; strong commercial relevance | varian.com | Business Development Director, Product Manager, Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Elekta | Medical technology vendor | Radiotherapy technology provider with direct relevance to conference topics | elekta.com | Account Executive, Clinical Specialist, Product Marketing Manager | Strong Market Fit, Attendance Not Confirmed |
| IBA (Ion Beam Applications) | Particle therapy vendor | Proton therapy and particle therapy supplier aligned with event theme | iba-worldwide.com | Sales Director, Technical Director, Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| Northwestern Medicine | Hospital system | Potential buyer for clinical radiotherapy innovation and research partnerships | nm.org | Director of Oncology, Clinical Research Manager, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Memorial Sloan Kettering Cancer Center | Cancer center | High-value oncology buyer and research collaborator | mskcc.org | Radiation Oncology Leader, Medical Physicist, Research Director | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Radiation Oncology | Clinical / Oncology | Director / Executive | Owns clinical adoption and equipment priorities |
| 2 | Chief Medical Physicist | Medical Physics | Executive / Director | Technical authority for therapy implementation and QA |
| 3 | Procurement Manager | Procurement / Supply Chain | Manager | Manages vendor evaluation and purchase process |
| 4 | Head of Oncology Research | Research / Clinical Trials | Director / Senior Manager | Drives study adoption and collaboration interest |
| 5 | Radiotherapy Service Manager | Operations / Clinical Services | Manager | Coordinates service delivery and workflow improvement |
| 6 | Clinical Engineering Manager | Biomedical Engineering | Manager / Senior Manager | Evaluates installation, maintenance, and uptime requirements |
| 7 | Director of Clinical Trials | Clinical Research | Director | Influences research-tech and service purchasing |
| 8 | Laboratory / Research Director | Research | Director / Senior Director | Responsible for scientific platforms and partnerships |
| 9 | Business Development Director | Commercial / Partnerships | Director | Potential partner or buyer for strategic collaborations |
| 10 | Product Manager, Radiotherapy Solutions | Product / Marketing | Manager | Tracks market needs and competitive clinical innovation |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core audience for oncology treatment delivery and equipment procurement | Hospitals, cancer centers, clinics |
| 2 | Medical Devices | Relevant to radiation delivery, imaging, QA, and clinical accessories | Therapy equipment and clinical systems |
| 3 | Medical Practice | Relevant for specialist oncology practices and physician-led groups | Clinician decision-makers |
| 4 | Research | Conference content is research-intensive | Academic and translational research buyers |
| 5 | Biotechnology | Relevant where oncology, radiobiology, and trial development overlap | Translational R&D partners |
| 6 | Pharmaceuticals | Some attendees may be involved in clinical trials and oncology combinations | Clinical study and partnership outreach |
| 7 | Biotechnology | Relevant where oncology, radiobiology, and trial development overlap | Translational R&D partners |
| 8 | Information Technology & Services | Workflow, planning, imaging, and research data systems are important in this space | Software, analytics, and integration vendors |
| 9 | Computer Software | Treatment planning, QA, and clinical data platforms matter to attendees | Planning and workflow software buyers |
| 10 | Government Administration | Public health systems and state-funded hospitals may attend or buy | Public-sector health procurement |
| 11 | Higher Education | Universities are major contributors to the science and training agenda | Academic research and collaborative buying |
| 12 | Aviation & Aerospace | Occasionally relevant through advanced accelerator and engineering ecosystems | Advanced engineering suppliers |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official event text provided by organizer website excerpt | No attendance number visible in the provided source text |
| Exhibitor count | Not publicly confirmed in the provided text | Confirmed unavailable | Official event text | Confirmed sponsors and exhibitors are referenced on the site, but count not provided |
| Buyer count | Not publicly confirmed | Confirmed unavailable | Official event text | Scientific conferences rarely publish buyer counts |
| Speaker count | Not publicly confirmed in the provided text | Confirmed unavailable | Official event text | Scientific programme and plenaries are referenced, but no total speaker count shown |
| Sponsor count | Not publicly confirmed in the provided text | Confirmed unavailable | Official event text | Sponsors and exhibitors page exists, but count not quoted in the provided excerpt |
| Historical attendance | Not publicly confirmed in provided source excerpt | Historical reference only | Official website navigation references “Statistics” | A direct attendance figure was not available in the supplied official text |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| FLASH radiotherapy | Clinical evidence, treatment delivery feasibility, and technology validation | Scientific education, pilot partnerships, and thought-leadership discussions | Delivery systems, dosimetry, research services |
| Particle therapy | Capex-heavy systems, facility planning, service and maintenance | Executive networking and center-operator meetings | Accelerators, beam control, service contracts |
| Clinical trials | Data capture, patient workflow, study execution | Research collaborations and vendor evaluation | CTMS, analytics, imaging, EDC |
| Medical physics / QA | Measurement, calibration, safety, and verification | Technical demos and peer-reviewed evidence | QA tools, detectors, software, phantoms |
| Treatment planning software | Optimization, automation, and interoperability | Product demos and workflow improvement discussions | Planning platforms, AI tools, integration services |
| Oncology research collaboration | Access to experts, datasets, and translational pathways | Partnerships, sponsored research, and advisory boards | Research support, CRO services, academic partnerships |
| Education and CME | Professional learning and protocol updates | Sponsorship, session support, educational branding | Educational grants, content sponsorship |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience is composed of clinicians, researchers, and technical buyers aligned to advanced oncology solutions |
| Decision-maker availability | High | Likely includes department heads, physicists, research directors, and procurement stakeholders |
| Data collection potential | Medium | Strong for attendee profiling, but limited public headcount data in the provided source excerpt |
| Apollo targeting potential | High | Clear targeting by hospital, medical device, research, biotech, and public-sector buyer segments |
| Geographic targeting potential | High | Useful for Portugal, Iberia, EU, UK, and global oncology networks |
| Best outreach approach | Technical and scientific | Lead with clinical evidence, research value, and workflow improvement rather than generic sales messaging |
| Overall lead quality | High | Strong for niche B2B prospecting in oncology technology, clinical research, and advanced therapy infrastructure |
| Best use case | B2B attendee list building, sponsor targeting, exhibitor prospecting, and account-based outreach | Best suited to specialized sales motions with technical qualification |
| Limitations / risks | Moderate | Public attendee and exhibitor counts are not fully disclosed in the provided source text; some buyer fit remains inferred |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Research; Biotechnology; Pharmaceuticals; Computer Software; Information Technology & Services; Government Administration; Higher Education; Medical Practice | Capture the most relevant buyer and influencer pools |
| Departments | Procurement, Clinical, Research, Operations, Biomedical Engineering, IT, Product, Business Development | Align outreach to purchase owners and technical evaluators |
| Seniority | Manager, Director, VP, CXO, Head, Senior Scientist | Prioritize budget holders and influential decision-makers |
| Job titles | Radiation Oncology Director, Chief Medical Physicist, Procurement Manager, Clinical Engineering Manager, Research Director, Head of Oncology, Product Manager, Business Development Director | Target likely buyers and champions |
| Geography | Portugal, Spain, France, Germany, Italy, United Kingdom, Benelux, Nordics, United States, Canada | Reach both local and international specialist buyers |
| Employee size | 201–500, 501–1,000, 1,001–5,000, 5,001+ | Focus on institutions with budget and implementation capacity |
| Keywords | radiotherapy, particle therapy, proton therapy, FLASH, SFRT, oncology, treatment planning, medical physics, dosimetry, clinical trial, radiobiology | Improve relevance and intent matching |
| Company type | Hospitals, research institutes, universities, medical device firms, public-sector health systems | Match the event’s buyer ecosystem |
| Suggested Boolean logic | (radiotherapy OR "particle therapy" OR proton OR FLASH OR SFRT OR oncology OR dosimetry) AND (procurement OR director OR manager OR head OR physicist OR researcher) | Build a high-intent list of technical and buying stakeholders |
Suggested Apollo Search Logic: Use combined account-level filters for healthcare and research organizations, then layer job-title and keyword matching around radiotherapy, oncology, particle therapy, and medical physics. For account-based outreach, prioritize institutions with active oncology programs, academic medical centers, and vendors in treatment planning or beam delivery ecosystems.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| FRPT Conference official website | Official organizer / event website | Event title, hybrid format, dates, city, country, conference positioning, programme, exhibition, sponsors/exhibitors references | High |
| FRPT-SFRT 2026 page | Official event landing page | Event description, 2–5 December 2026 date line, Lisbon & Online format, focus on FLASH, particle therapy, and SFRT | High |
| Official site navigation references | Official website structure | Presence of programme, industry, exhibition, statistics, confirmed sponsors and exhibitors pages | Medium |
Verification note: The report uses the official event website excerpt as the primary source of truth. A specific physical venue name and attendance figures were not publicly confirmed in the supplied source text, so they are intentionally left unverified.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Flash Radiotherapy & Particle Therapy - FRPT Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds